Neon Therapeutics

YTD

ALL

Why Robinhood?

You can watch NTGN and buy or sell other stocks, ETFs, and their options commission-free!

About NTGN

Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens.

CEO

Hugh O'Dowd, MBA

CEOHugh O'Dowd, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2013

Founded2013

Employees

—

Employees—

NTGN Key Statistics

Market cap

88.93M

Market cap88.93M

Price-Earnings ratio

-1.14

Price-Earnings ratio-1.14

Dividend yield

—

Dividend yield—

Average volume

665.16K

Average volume665.16K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$5.97

52 Week high$5.97

52 Week low

$0.88

52 Week low$0.88

People also own

Based on the portfolios of people who own NTGN. This list is generated using Robinhood data, and it’s not a recommendation.